Progressive
Care Inc. Reports
Record
Revenue of $3.4
Million for July 2019
MIAMI,
FL -- August 21, 2019 -- InvestorsHub NewsWire
-- Progressive
Care Inc. (OTCQB:
RXMD),
a personalized healthcare services and technology company, today
announced record
revenues of approximately
$3.4
Million
for July
2019
and an 73%
increase in prescriptions filled at over
46,400
total.
The
Company recorded an
88%
increase
in gross revenues at $3.4 million
exclusive
of PBM fees and over
46,000
prescriptions filled. The Company has been actively
pursuing growth strategies that will enhance our core
business. We are currently working to
optimize profitability by focusing sales efforts on patients whose
medication benefits are managed by PBMs that have sustainable
reimbursement rates or do not charge excessive fees.
"We have aggressively pursued
sales and prescription growth throughout the
year,"
said S. Parikh Mars, Chief Executive Officer of Progressive Care
Inc. "While we feel that growth is
in our best interest, it is important that we make gains in the
right way. By presenting ourselves to patients enrolled in drug
benefit programs that adequately compensate the pharmacy, we will
be able to improve our quality of care while also increasing our
bottom line."
For
more information about Progressive Care, please visit the
company's website.
Connect and stay
in touch with us on social media:
Progressive
Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo,
LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About
Progressive Care Inc.
Progressive Care
Inc. (OTCQB: RXMD), through its
PharmCo and Five Star
pharmacies, is a South Florida health
services organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements
contained herein that are not based upon current or historical fact
are forward-looking in nature and constitute forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934.
Such forward-looking statements reflect the Company's expectations
about its future operating results, performance, and opportunities
that involve substantial risks and uncertainties. These statements
include but are not limited to statements regarding the intended
terms of the offering, closing of the offering and use of any
proceeds from the offering. When used herein, the words
"anticipate," "believe," "estimate," "upcoming," "plan," "target,"
"intend" and "expect" and similar expressions, as they relate to
Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Investor
Relations Contact:
Armen Karapetyan,
Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public
Relations Contact:
Kathleen
Gonzales, CMW Media
Kathleen@cmwmedia.com
www.cmwmedia.com
Web and
Application Development Contact:
Marcello Jaspan,
Mass Ventures Corp
Marcello@massventurescorp.com
www.massventurescorp.com